(Q44805063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Daytime sleepiness in epilepsy patients receiving topiramate monotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Maria Laura Manca

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Renato Galli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Michelangelo Maestri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Chiara Pizzanelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Monica Fabbrini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Alfonso Iudice

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Luigi Murri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

333-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15030495%20AND%20SRC:MED&resulttype=core&format=json

Topiramate: a review of preclinical, pharmacokinetic, and clinical data

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Topiramate titration and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Evaluation of sleepiness in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Multiple sleep latency tests in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Daytime vigilance and quality of life in epileptic patients treated with vagus nerve stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

A pooled analysis of adjunctive topiramate in refractory partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2004.47803.X